Metformins role has been increasingly acknowledged by different nations, making it the preferred medication for managing type 2 diabetes mellitus (T2DM) in clinical settings ( In addition to treating T2DM, metformin modestly reduces body weight gain, which may be achieved by upregulating growth differentiation factor 15 (GDF15) (Khunti et al., 2021
Any programme designed to the WHO BMI 30 obesity-only threshold systematically excludes much of the population the clinical evidence supports treating including a large share of Asian-Canadian populations, where metabolic risk arrives at lower BMI
This is not a formal ceiling because no FDA-approved limit exists, but it represents the upper range of what is supported by preclinical scaling and provider experience
When to Seek Medical Attention While mild headaches are common, certain symptoms should never be ignored
Krause, M., Ludwig, M
This led to a sharp decline in new-to-brand volume as weight loss patients who were less likely to have payer coverage and thus required transitional assistance were now excluded from eligibility